Clinical Trial Update: A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating KK2260 in patients with advanced or metastatic solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• KK2260

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Advanced or Metastatic Solid Tumors | Phase 1 | Status: RECRUITING